首页> 外国专利> method for predicting or monitoring whether a patient suffering from cancer or an autoimmune disease will respond or respond to treatment with a tlr-9 agonist, tlr-9 agonist for use in a cancer treatment method, and a kit to predict or monitor if a patient suffering from cancer or autoimmune disease will respond or respond to treatment with a tlr-9 agonist

method for predicting or monitoring whether a patient suffering from cancer or an autoimmune disease will respond or respond to treatment with a tlr-9 agonist, tlr-9 agonist for use in a cancer treatment method, and a kit to predict or monitor if a patient suffering from cancer or autoimmune disease will respond or respond to treatment with a tlr-9 agonist

机译：预测或监测患有癌症或自身免疫性疾病的患者是否会对tlr-9激动剂，tlr-9激动剂用于癌症治疗方法的治疗产生反应或反应的方法，以及用于预测或监测患者是否使用的试剂盒患有癌症或自身免疫性疾病的患者将对tlr-9激动剂做出反应或做出反应

页面导航

摘要
著录项
相似文献

摘要

summary method for predicting or monitoring whether a patient suffering from cancer or an autoimmune disease will respond or respond to treatment with a tlr-9 agonist, tlr-9 agonist for use in a cancer treatment method, and kit to predict or To monitor whether a patient suffering from cancer or autoimmune disease will respond or respond to treatment with a tlr-9 agonist the present invention generally relates to the identification of cancer patients as to whether they may respond to specific therapies. more particularly, the invention relates to a method and means for identifying a responder to therapy tI-9 agonists. 1/1

机译：预测或监测患有癌症或自身免疫性疾病的患者是否会对tlr-9激动剂，用于癌症治疗方法的tlr-9激动剂的治疗产生反应或反应的概要方法以及用于预测或监测患有癌症或自身免疫性疾病的患者将对tlr-9激动剂的治疗有反应或有反应。本发明通常涉及鉴定癌症患者是否对特定疗法有反应。更具体地，本发明涉及用于鉴定对治疗tI-9激动剂的应答者的方法和手段。 1/1

著录项

公开/公告号BR112015029852A2

专利类型
公开/公告日2017-07-25

原文格式PDF
申请/专利权人 MOLOGEN AG;
展开▼

申请/专利号BR20151129852
发明设计人 BURGHARDT WITTIG;KERSTIN KAPP;MANUEL SCHMIDT;MATTHIAS SCHROFF;
展开▼

申请日2014-05-15
分类号G01N33/50;G01N33/574;
国家 BR
入库时间 2022-08-21 13:40:00

相似文献

专利
外文文献
中文文献